









市場行情
/
股票
/
nasdaq-holx
/

Hologic Inc

HOLX

74.870USD

-0.010-0.01%

收盤 01/09, 16:00（美東）報價延遲15分鐘

16.66B總市值

29.93本益比TTM



Hologic Inc

74.870

-0.010-0.01%

概覽公司財務分析

概覽

公司

財務

分析

關於 Hologic Inc 公司

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Hologic Inc簡介



公司代碼HOLX

公司名稱Hologic Inc

上市日期Mar 01, 1990

CEOMacmillan (Stephen P)

員工數量7070

證券類型Ordinary Share

年結日Mar 01

公司地址250 Campus Drive

城市MARLBOROUGH

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編01752

電話15082632900

網址https://www.hologic.com/

公司代碼HOLX

上市日期Mar 01, 1990

CEOMacmillan (Stephen P)

Hologic Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Ms. Christiana Stamoulis

Independent Director

45.47K

-1864.00%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+15736.00%

Mr. Essex D. Mitchell

Chief Operating Officer

20.26K

-38922.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.51K

-90.00%

Mr. Charles J. Dockendorff, CPA

Independent Director

16.94K

-1864.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

+12019.00%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

7.40K

-1864.00%

Ms. Nanaz Mohtashami

Independent Director

2.32K

-1864.00%

Ms. Stacey D. Stewart

Independent Director

1.73K

-1864.00%

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

名稱

名稱/職務

職務

持股

持股變動

Ms. Christiana Stamoulis

Independent Director

45.47K

-1864.00%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+15736.00%

Mr. Essex D. Mitchell

Chief Operating Officer

20.26K

-38922.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.51K

-90.00%

Mr. Charles J. Dockendorff, CPA

Independent Director

16.94K

-1864.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

+12019.00%

收入明細

單位: USD更新時間: 1月6日週二

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Disposables

2.62B

63.84%

Service

825.50M

20.13%

Capital equipment, components and software

638.40M

15.57%

Other

18.90M

0.46%

地區USD

名稱

營收

佔比

United States

3.05B

74.33%

Europe

591.00M

14.41%

Asia

243.30M

5.93%

Rest of World

218.30M

5.32%

業務

地區

業務USD

名稱

營收

佔比

Disposables

2.62B

63.84%

Service

825.50M

20.13%

Capital equipment, components and software

638.40M

15.57%

Other

18.90M

0.46%

股東統計

更新時間: 1月10日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.66%

BlackRock Institutional Trust Company, N.A.

5.57%

Manulife Investment Management (North America) Limited

4.68%

State Street Investment Management (US)

4.47%

其他

63.90%

持股股東

佔比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.66%

BlackRock Institutional Trust Company, N.A.

5.57%

Manulife Investment Management (North America) Limited

4.68%

State Street Investment Management (US)

4.47%

其他

63.90%

股東類型

持股股東

佔比

Investment Advisor

56.89%

Investment Advisor/Hedge Fund

28.21%

Hedge Fund

6.68%

Research Firm

2.40%

Pension Fund

2.30%

Bank and Trust

1.72%

Sovereign Wealth Fund

1.26%

Individual Investor

0.85%

Family Office

0.05%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

1591

219.20M

98.26%

-26.04M

2025Q3

1587

223.55M

100.44%

-14.31M

2025Q2

1594

230.47M

103.62%

-13.07M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

26.11M

11.71%

-587.96K

-2.20%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

21.55M

9.66%

-2.53M

-10.52%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

12.44M

5.57%

-516.22K

-3.99%

Sep 30, 2025

Manulife Investment Management (North America) Limited

10.45M

4.68%

-572.01K

-5.19%

Sep 30, 2025

State Street Investment Management (US)

9.98M

4.47%

-122.10K

-1.21%

Sep 30, 2025

Geode Capital Management, L.L.C.

5.90M

2.64%

+68.67K

+1.18%

Sep 30, 2025

Victory Capital Management Inc.

5.47M

2.45%

-28.86K

-0.52%

Sep 30, 2025

Invesco Advisers, Inc.

4.36M

1.96%

+35.56K

+0.82%

Sep 30, 2025

Black Creek Investment Management, Inc.

3.74M

1.68%

-284.48K

-7.06%

Sep 30, 2025

Citadel Advisors LLC

3.00M

1.34%

-712.33K

-19.21%

Sep 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

First Trust Nasdaq Lux Digi Health Solutions ETF

4.41%

LeaderShares AlphaFactor Tactical Focused ETF

3.17%

John Hancock Fundamental All Cap Core ETF

3.15%

AltShares Event-Driven ETF

2.95%

ProShares Merger ETF

2.78%

First Trust Indxx Medical Devices ETF

2.19%

Strategas Global Policy Opportunities ETF

2.08%

State Street SPDR S&P Health Care Equipment ETF

2.02%

iShares U.S. Medical Devices ETF

1.95%

Brandes US Small-Mid Cap Value ETF

1.94%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比4.41%

LeaderShares AlphaFactor Tactical Focused ETF

佔比3.17%

John Hancock Fundamental All Cap Core ETF

佔比3.15%

AltShares Event-Driven ETF

佔比2.95%

ProShares Merger ETF

佔比2.78%

First Trust Indxx Medical Devices ETF

佔比2.19%

Strategas Global Policy Opportunities ETF

佔比2.08%

State Street SPDR S&P Health Care Equipment ETF

佔比2.02%

iShares U.S. Medical Devices ETF

佔比1.95%

Brandes US Small-Mid Cap Value ETF

佔比1.94%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Hologic Inc的前五大股東是誰？



Hologic Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：26.11M
佔總股份比例：11.71%。
T. Rowe Price Investment Management, Inc.
持有股份：21.55M
佔總股份比例：9.66%。
BlackRock Institutional Trust Company, N.A.
持有股份：12.44M
佔總股份比例：5.57%。
Manulife Investment Management (North America) Limited
持有股份：10.45M
佔總股份比例：4.68%。
State Street Investment Management (US)
持有股份：9.98M
佔總股份比例：4.47%。